Massive cerebral venous sinus thrombosis in vaccine-induced immune thrombotic thrombocytopenia after ChAdOx1 nCoV-19 serum: case report of a successful multidisciplinary approach
- 10 January 2022
- journal article
- research article
- Published by Springer Science and Business Media LLC in Neurological Sciences
- Vol. 43 (3), 1499-1502
- https://doi.org/10.1007/s10072-021-05805-y
Abstract
We report a case of massive cerebral venous sinus thrombosis in the contest of vaccine-induced immune thrombotic thrombocytopenia that required the rapid coordination of many specialists from different departments, notably emergency, neurology, neuroradiology, hematology, and neurosurgery. The patient was rapidly treated with steroids, immunoglobulin, and fondaparinux. She underwent within 6 h after hospital admission a mechanical thrombectomy in order to allow flow restoration in cerebral venous systems. Neuroendovascular treatment in cerebral venous thrombosis related to VITT has never been described before. It can represent a complementary tool along with the other therapies and a multidisciplinary approach.Keywords
This publication has 11 references indexed in Scilit:
- COVID‐19 Vaccine‐Associated Cerebral Venous Thrombosis in GermanyAnnals of Neurology, 2021
- Management of cerebral and splanchnic vein thrombosis associated with thrombocytopenia in subjects previously vaccinated with Vaxzevria (AstraZeneca): a position statement from the Italian Society for the Study of Haemostasis and Thrombosis (SISET)2021
- SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia treated with immunoglobulin and argatrobanThe Lancet, 2021
- Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 VaccinationThe New England Journal of Medicine, 2021
- Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 VaccinationThe New England Journal of Medicine, 2021
- COVID‐19 vaccine‐associated immune thrombosis and thrombocytopenia (VITT): Diagnostic and therapeutic recommendations for a new syndromeEuropean Journal of Haematology, 2021
- A flow cytometric assay to detect platelet-activating antibodies in VITT after ChAdOx1 nCov-19 vaccinationBlood, 2021
- Effect of Endovascular Treatment With Medical Management vs Standard Care on Severe Cerebral Venous ThrombosisJAMA Neurology, 2020